Abstract
Protein aggregation in muscle fibers may be a nonspecific phenomenon such as occurring in cores or ragged red fibers. However, it may also be a disease-specific and disease-significant phenomenon constituting protein aggregate myopathies (PAMs). These may be divided into two classes: The first one is marked by impaired extralysosomal degradation of proteins, catabolic PAM, encompassing desmin-related myopathies. Mutant proteins, that is, desmin, myotilin, or α-B crystallin, defy protein degradation, aggregate and associate with other proteins within muscle fibers, hence marking desminopathies, myotilinopathies, and α-B crystallinopathies. A second class of PAM encompasses those apparently associated with developmental errors though, again, based on mutations in genes for myofibrillar proteins, foremost sarcomeric actin and myosin. Here, actinopathies and myosinopathies often occur early in childhood while catabolic PAMs are largely of adult or even late onset. The common principle of these PAMs is that immunohistochemical identification of certain proteins resulted in subsequent molecular analysis of respective genes, identification of mutations, and demonstration of mutant proteins as important components of these protein aggregates.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Agrawal, P. B., Strickland, C. D., Midgett, C., Morales, A., Newburger, D. E., Poulos, M. A., Tomczak, K. K., Ryan, M. M., Iannaccone, S. T., Crawford, T. O., Laing, N. G., and Beggs, A. H. (2004). Heterogeneity of nemaline myopathy cases with skeletal muscle α-actin gene mutations. Ann. Neurol. 56:86–96.
Amato, A. A., Gronseth, G. S., Jackson, C.-E., Wolfe, G. L., Katz, J. S., Bryan, W. W., and Barohn, R. J. (1996). Inclusion body myositis: clinical and pathological boundaries. Ann. Neurol. 40:581–586.
Amemiya, K., and Dalakas, M. C. (1998). The T-cell receptor repertoire of endomysial lymphocytes in patients with inclusion body myositis (IBM) remains restricted over time: studies in repeated muscle biopsies (P04.015). Neurology 50:A204.
Arbustini, E., Morbini, P., Grasso, M., Fasani, R., Verga, L., Bellini, O., Dal Bello, B., Campana, C., Piccolo, G., Febo, O., Opasich, C., Gavazzi, A., and Ferrans, V. J. (1998). Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. J. Am. Coll. Cardiol. 32:645–653.
Argov, Z., and Soffer, D. (2002). Hereditary inclusion body myopathies. In: Karpati, G. (ed), Structural and Molecular Basis of Skeletal Muscle Diseases. ISN Neuropath Press, Basel, pp. 274–276.
Askanas, V., and Engel, W. K. (2001). Inclusion-body myositis. Newest concepts of pathogenesis and relation to aging and Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:1–14.
Askanas, V., and Engel, A. G. (2003). Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging. J. Child Neurol. 18:185–190.
Askanas, V., Engel, W. K., and Alvarez, R. B. (1992). Light and electron microscopic localization of ß-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am. J. Pathol. 141:31–36.
Banwell, B. L., and Engel, A. G. (2000). α-B-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 54:1033–1041.
Barohn, R. J., Brumback, R. A., and Mendell, J. R. (1994). Hyaline body myopathy. Neuromuscul. Disord. 4:257–262.
Bertini, E., Bosman, C., Ricci, E., Servidei, S., Boldrini, R., Sabatelli, M., and Salviati, G. (1991). Neuromyopathy and restrictive cardiomyopathy with accumulation of intermediate filaments: a clinical, morphological and biochemical study. Acta Neuropathol. (Berl.) 81:632–640.
Bertini, E., Salviati, G., Apollo, F., Ricci, E., Servidei, S., Broccolini, A., Papacci, M., and Tonali, P. (1994). Reducing body myopathy and desmin storage in skeletal muscle: morphological and biochemical findings. Acta Neuropathol. (Berl.) 87:106–112.
Bohlega, S., Abu-Amero, S. N., Wakil, S. M., Carroll, P., Al-Amr, R., Lach, B., Al-Sayed, Y., Cupler, J., and Meyer, B. F. (2004). Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy. Neurology 62:1518–1521.
Bornemann, A., Bloch, P., Petersen, M., and Schmalbruch, H. (1996). Fatal congenital myopathy with actin filament deposits. Acta Neuropathol. (Berl.) 92:104–108.
Bönnemann, C., Thompson, T. G., van der Ven, P. F. M., Goebel, H. H., Warlo, I., Vollmers, B., Reimann, J., Herms, J., Gautel, M., Takada, F., Beggs, A. H., Fürst, D. O., Kunkel, L. M., Hanefeld, F., and Schröder, R. (2003). Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle. J. Neurol. Sci. 206:71–78.
Broccolini, A., Engel, K. W., Alvarez, R. B., and Askanas, V. (2000). Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein. Am. J. Pathol. 156:1151–1155.
Cancilla, P. A., Kalyanaraman, K., Verity, M. A., Munsat, T., and Pearson, C. M. (1971). Familial myopathy with probable lysis of myofibrils in type I fibres. Neurology 21:579–585.
Ceuterick, C., Martin, J.-J., and Martens, C. (1993). Hyaline bodies in skeletal muscle of a patient with a mild chronic nonprogressive congenital myopathy. Clin. Neuropathol. 12:79–83.
Dagvadorj, A., Goudeau, B., Hilton-Jones, D., Blancato, J. K., Shatunov, A., Simon-Casteras, M., Squier, W., Nagle, J. W., Goldfarb, L. G., and Vicart, P. (2003). Respiratory insufficiency in desminopathy patients caused by introduction of proline residues in desmin c-terminal alpha-helical segment. Muscle Nerve 27:643–645.
Dagvadorj, A., Olivé, M., Urtizberea, J.-A., Halle, M., Bönnemann, C., Park, K.-Y., Goebel, H. H., Ferrer, I., Vicart, P., Dalakas, M. C., and Goldfarb, L. (2004). A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J. Neurol. 251:143–149.
Dalakas, M. C., Park, K.-Y., Semino-Mora, C., Lee, H.-S., Sivakumar, K., and Goldfarb, L. (2000). Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N. Engl. J. Med. 342:770–780.
Dalakas, M. C., Dagvadorj, A., Goudeau, B., Park, K.-Y., Takeda, K., Simon-Casteras, M., Vasconcelos, O., Sambuughin, N., Shatunov, A., Nagle, J. W., Sivakumar, K., Vicart, P., and Goldfarb, L. G. (2003). Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. Neuromuscul. Disord. 55:563–577.
De Bleecker, J. L., Ertl, B. B., and Engel, A. G. (1996a). Patterns of abnormal protein expression in target formations and unstructured cores. Neuromuscul. Disord. 6:339–349.
De Bleecker, J. L., Engel, A. G., and Ertl, B. B. (1996b). Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J. Neuropathol. Exp. Neurol. 55:563–577.
Desnuelle, C., Paquis, V., Paul, R., Saunières, A., Alvarez, R.B., and Askanas, V. (1998). mtDNA analysis in muscle of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. In: Askanas, V., Serratrice, G., and Engel, K. W. (eds.), Inclusion-Body Myositis and Myopathies. Cambridge University Press, Cambridge, pp. 318–328.
Dubowitz, V. (1985). Muscle Biopsy: A Practical Approach. Baillière Tindall, London, pp. 664–670.
Engel, A. G. (1999). Myofibrillar myopathy (editorial). Ann. Neurol. 46:681–683.
Fardeau, M., Vicart, P., Caron, A., Chateau, D., Chevalay, M., Collin, H., Chapon, F., Duboc, D., Eymard, B., Tomé, F. M. S., Dupret, J. M., Paulin, D., and Guicheney, P. (2000). Myopathie familiale avec surcharge en desmine, sous forme de matériel granulo-filamentaire dense en microscopie électronique, avec mutation dans le gène de l’alpha-B-cristalline. Rev. Neurol. (Paris) 156:497–504.
Ferreiro, A., Quijano-Roy, S., Pichereau, C., et al. (2002). Mutations of the selenoprotein N gene, implicated in rigid spine muscular dystrophy, cause the classical phenotype of multi-minicore disease. Am. J. Hum. Genet. 71:739–749.
Ferreiro, A., Ceuterick-de Groote, C., Marks, J. J., Goesmans, N., Schreiber, G., Hanefeld, F., Fardeau, M., Martin, J.-J., Goebel, H. H., Richard, P., Guicheney, P., and Bönnemann, C. (2004). Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann. Neurol. 55: 676–686.
Ferrer, I., Martín, B., Castaño, J. G., Lucas, J. J., Moreno, D., and Olivé, M. (2004). Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J. Neuropathol. Exp. Neurol. 63:484–498.
Fidzianska, A., Drac, H., and Kaminska, A. (1999). Familial inclusion body myopathy with desmin storage. Acta Neuropathol. (Berl.) 97:509–514.
Fuchs, E. (1996). The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu. Rev. Genet. 30:197–231.
Goebel, H. H., Muller, J., Gillen, H. W., and Merritt, A. D. (1978). Autosomal dominant “spheroid body myopathy.” Muscle Nerve 1:14–26.
Goebel, H. H., Schloon, H., and Lenard, H. G. (1981). Congenital myopathy with cytoplasmic bodies. Neuropediatrics 12:166–180.
Goebel, H. H., and Lenard, H. G. (1992). Congenital myopathies. In: Rowland, L. P., and DiMauro, S. (eds.), Handbook of Clinical Neurology, Volume 18/62. Elsevier Science Publishers B.V., Amsterdam, pp. 331–367.
Goebel, H. H. (1995). Desmin-related neuromuscular disorders. Muscle Nerve 18:1306–1320.
Goebel, H. H. (1997). Desmin-related myopathies. Curr. Opin. Neurol. 10:426–429.
Goebel, H. H., Anderson, J. R., Hübner, C., Oexle, K., and Warlo, I. (1997). Congenital myopathy with excess of thin myofilaments. Neuromuscul. Disord. 7:160–168.
Goebel, H. H., and Warlo, I. A. P. (2000). Progress in desmin-related myopathies. J. Child Neurol. 15:565–572.
Goebel, H. H., and Borchert, A. (2002). Protein surplus myopathies and other rare congenital myopathies. Semin. Pediatr. Neurol. 9:160–170.
Goebel, H. H., Brockmann, K., Bönnemann, C., Warlo, I. A. P., Hanefeld, F., Labeit, S., and Durling, H. J. (2004). Actinrelated myopathy without any missense mutation in the ACTA1 gene. J. Child Neurol. 19:149–153.
Goldfarb, L. G., Park, K.-Y., Cervenáková, S., Lee, H.-S., Vasconcelos, O., Nagle, J. W., Semino-Mora, C., Sivakumar, K., and Dalakas, M. C. (1998). Missense mutations in desmin associated with familial cardiac and skeletal myopathy (letter). Nat. Genet. 19:402–403.
Goldfarb, L. G., Vicart, P., Goebel, H. H., and Dalakas, M. C. (2004). Desmin myopathy. Brain 127:723–734.
Griggs, R. C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J. R., and Rowland, L. P. (1995). Inclusion body myositis and myopathies. Ann. Neurol. 38:705–713.
Horowitz, S. H., and Schmalbruch, H. (1994). Autosomal dominant distal myopathy with desmin storage: a clinicopathologic and electrophysiologic study of a large kinship. Muscle Nerve 17:151–160.
Hübner, G., and Pongratz, D. (1982). Granularkörpermyopathie (sog. reducing body myopathy). Pathologe 3:111–113.
Kaindl, A. M., Rüschendorf, F., Krause, S., Goebel, H. H., Koehler, K., Becker, C., Pongratz, D., Müller-Höcker, J., Nürnberg, P., Stoltenburg-Didinger, G., Lochmüller, H., and Huebner, A. (2004). Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J. Med. Genet. 41:842–848.
Karpati, G., and Carpenter, S. (1992). Skeletal muscle in neuromuscular diseases. In: Rowland, L. P., and DiMauro, S. (eds.), Myopathies-Handbook of Clinical Neurology, Volume 18/62. Elsevier Science Publishers B.V., Amsterdam, pp. 1–48.
Kreis, T., and Vale, R., Eds. (1998). Guidebook to the Cytoskeletal and Motor Proteins, 2nd ed. Oxford University Press, Oxford.
Li, D., Tapscoft, T., Gonzales, O., Burch, P. E., Quinones, M. A., Zoghbi, W. A., Hill, R., Bachinski, L. L., Mann, D. L., and Roberts, R. (1999). Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100:461–464.
Lindberg, C., Oldfors, A., and Hedström, A. (1990). Inclusion body myositis: peripheral nerve involvement: combined morphological and electrophysiological studies on peripheral nerves. J. Neurol. Sci. 99:327–338.
Lobrinus, J. A., Janzer, R. C., Kuntzer, T., Matthieu, J.-M., Pfend, G., Goy, J.-J., and Bogousslavsky, J. (1998). Familial cardiomyopathy and distal myopathy with abnormal desmin accumulation and migration. Neuromuscul. Disord. 8:77–86.
Martinsson, T., Oldfors, A., Darin, N., Berg, K., Tajsharghi, H., Kyllerman, M., and Wahlström, J. (2000). Autosomal dominant myopathy: missense mutation (Glu-706 to Lys) in the myosin heavy chain IIa gene. Proc. Natl. Acad. Sci. USA 96:14614–14619.
Masuzugawa, S., Kuzuhara, S., Narita, Y., Naito, Y., Taniguchi, A., and Ibi, T. (1997). Autosomal dominant hyaline body myopathy presenting as scapuloperoneal syndrome: clinical features and muscle pathology. Neurology 48:253–257.
Mendell, J. R., Sahenk, Z., Gales, T., and Paul, L. (1991). Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch. Neurol. 48:1229–1234.
Mirabella, M., Alvarez, R. B., Bilak, M., Engel, W. K., and Askanas, V. (1996). Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathy. J Neuropathol. Exp. Neurol. 55:774–786.
Nakano, S., Engel, A. G., Waclawik, A. J., Emslie-Smith, A. M., and Busis, N. A. (1996). Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J. Neuropathol. Exp. Neurol. 55:549–562.
Nakano, S., Shinde, A., Kawashima, S., Nakamura, S., Akiguchi, I., and Kimura, J. (2001). Inclusion body myositis. Neurology 56:87–93.
Nowak, K., Wattanasirichaigoon, D., Goebel, H. H., Wilce, M., Pelin, K., Donner, K., Jacob, R., Hübner, C., Oexle, K., Anderson, J., Verity, C. M., North, K. N., Iannaccone, S. T., Müller, C. R., Nürnberg, P., Muntoni, F., Sewry, C., Hughes, I., Sutphen, R., Lacson, A. G., Swoboda, K. J., Vigneron, J., Wallgren-Pettersson, C., Beggs, A. H., and Laing, N. B. (1999). Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy. Nat. Genet. 23:208–212.
Oldfors, A., and Lindberg, C. (1999). Inclusion body myositis. Curr. Opin. Neurol. 12:527–533.
Oldfors, A., Darin, N., and Martinsson, T. (2002). Autosomal dominant myosin heavy chain IIa myopathy. In: Karpati, G. (ed.), Structural and Molecular Basis of Skeletal Muscle Diseases. ISN Neuropath Press, Basel, pp. 85–87.
Osborn, M., and Goebel, H. H. (1983). The cytoplasmic bodies in a congenital myopathy can be stained with antibodies to desmin, the muscle-specific intermediate filament protein. Acta Neuropathol. (Berl.) 62:149–152.
Parain, K., Herasse, M., Monnier, N., Lunardi, J., Marty, I., Romero, N. B., and Ferreiro, A. (2004). Proteins implicated in Ca2+ homeostasis: expression patterns in genetically characterized core myopathies (abstract G.P.8.01). Neuromuscul. Disord. 14:588.
Rappaport, L., Contard, F., Samuel, J. L., Delcayre, C., Marotte, F., Tomé, F., and Fardeau, M. (1988). Storage of phosphorylated desmin in a familial myopathy. FEBS Lett. 231:421–425.
Reichmann, H., Goebel, H. H., Schneider, C., and Toyka, K. V. (1997). Familial mixed congenital myopathy with rigid spine phenotype. Muscle Nerve 20:411–417.
Sabatelli, M., Bertini, E., Ricci, E., Salviati, G., Magi, S., Papacci, M., and Tonali, P. (1992). Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle. J. Neurol. Sci. 109:1–10.
Sahgal, V., and Sahgal, S. (1977). A new congenital myopathy: a morphological, cytochemical and histochemical study. Acta Neuropathol. (Berl.) 37:225–230.
Schröder, R., Goudeau, B., Simon, M. C., Fischer, D., Eggermann, T., Clemen, C. S., Li, Z., Reimann, J., Xue, Z., Rudnik-Schöneborn, S., Zerres, K., van der Ven, P. F., Fürst, D. O., Kunz, W. S., and Vicart, P. (2003). On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum. Mol. Genet. 12:657–669.
Schröder, J. M., Durling, H. J., and Laing, N. B. (2004). Actin myopathy with nemaline bodies, intranuclear rods, and a heterozygous mutation in ACTA1 (Asp154Asn). Acta Neuropathol. (Berl.) 108:250–256.
Selcen, D., Krueger, B. R., and Engel, A. G. (2002). Familial cardioneuromyopathy with hyaline masses and nemaline rods: a novel phenotype. Ann. Neurol. 51:224–234.
Selcen, D., and Engel, A. G. (2003). Myofibrillar myopathy caused by novel dominant negative α-B-crystallin mutations. Ann. Neurol. 54:804–810.
Selcen, D., and Engel, A. G. (2004). Mutations in myotilin cause myofibrillar myopathy. Neurology 62:1363–1371.
Selcen, D., Ohno, K., and Engel, A. G. (2004). Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 127:439–451.
Sjöberg, G., Saavedra-Matiz, C. A., Rosen, D. R., Wijsman, E. M., Borg, K., Horowitz, S. H., and Sejersen, T. (1999). A missense mutation in the desmin rod domain is associated with autosomal distal myopathy, and exerts a dominant negative effect on filament formation. Hum. Mol. Genet. 8:2191–2198.
Sparrow, J. C., Nowak, K. J., Durling, H. J., Beggs, A. H., Wallgren-Pettersson, C., Romero, N. B., Nonaka, I., and Laing, N. B. (2003). Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1). Neuromuscul. Disord. 13:519–531.
Tajsharghi, H., Thornell, L.-E., Darin, N., Martinsson, T., Kyllerman, M., Wahlström, J., and Oldfors, A. (2002). Myosin heavy chain IIa gene mutation E706K is pathogenic and its expression increases with age. Neurology 58:780–786.
Tajsharghi, H., Thornell, L.-E., Lindberg, C., Lindvall, B., Henriksson, K. G., and Oldfors, A. (2003). Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann. Neurol. 54:494–500.
Vicart, P., Caron, A., Guicheney, P., Li, Z., Prévost, M.-C., Faure, A., Chateau, D., Chapon, F., Tomé, F., Dupret, J.-M., Paulin, D., and Fardeau, M. (1998). A missense mutation in the alpha-B crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 20:92–95.
Viegas-Péquignot, E., Lin, Z. L., Dutrillaux, B., Apiou, F., and Paulin, D. (1989). Assignment of human desmin gene to band 2q35 by nonradioactive in situ hybridization. Hum. Genet. 83:33–36.
Vita, G., Migliorato, A., Baradello, A., Mazzeo, A., Rodolico, C., Falsaperla, R., and Messina, C. (1994). Expression of cytoskeletal proteins in central core disease. J. Child Neurol. 124:71–76.
Wallgren-Pettersson, C., Pelin, K., Nowak, K. J., Muntoni, F., Romero, N. B., Goebel, H. H., North, K. N., Beggs, A. H., Laing, N. B., and the International Consortium on Nemaline Myopathy (2004). Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle α-actin. Neuromuscul. Disord. 14:461–470.
Yunis, E. J., and Samaha, F. J. (1971). Inclusion body myositis. Lab. Invest. 25:240–248.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Vrabie, A., Goebel, H.H. (2007). Protein Aggregation in Muscle Fibers and Respective Neuromuscular Disorders. In: Uversky, V.N., Fink, A.L. (eds) Protein Misfolding, Aggregation, and Conformational Diseases. Protein Reviews, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36534-3_18
Download citation
DOI: https://doi.org/10.1007/978-0-387-36534-3_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36529-9
Online ISBN: 978-0-387-36534-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)